MedPath

Pharbedryl

Drug Facts

Approved
Approval ID

3ef18965-bafb-cc19-e063-6394a90af17d

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Sep 16, 2025

Manufacturers
FDA

ST. MARY'S MEDICAL PARK PHARMACY

DUNS: 063050751

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diphenhydramine HCl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60760-699
Application NumberM010
Product Classification
M
Marketing Category
C200263
G
Generic Name
Diphenhydramine HCl
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 16, 2025
FDA Product Classification

INGREDIENTS (10)

FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
D&C RED NO. 28Inactive
Code: 767IP0Y5NH
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
DIPHENHYDRAMINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 1
Code: TC2D6JAD40
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 12/31/2024

60760-699

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 1/11/2021

Uses

  • Temporarily relieves these symptoms associated with the common cold, hay fever, or other respiratory allergies:
  • sneezing
  • itching of the nose or throat
  • runny nose
  • itchy, watery eyes
  • Temporarily relieves these symptoms due to common cold:
  • runny nose
  • sneezing

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 6/13/2023

Active ingredient (in each capsule)

Diphenhydramine HCl 25mg

Purpose

Antihistamine

WARNINGS SECTION

LOINC: 34071-1Updated: 1/11/2021

Warnings

Do not use

  • to make child sleepy
  • with any other product containing diphenhydramine, even one used on skin

OTC - ASK DOCTOR SECTION

LOINC: 50569-3Updated: 1/11/2021

Ask a doctor before use if you have

  • trouble urinating due to an enlarged prostate gland
  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers

OTC - WHEN USING SECTION

LOINC: 50567-7Updated: 1/11/2021

When using this product

  • avoid alcoholic drinks
  • marked drowsiness may occur
  • excitability may occur, especially in children
  • alcohol, sedatives and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

OTC - PREGNANCY OR BREAST FEEDING SECTION

LOINC: 53414-9Updated: 1/11/2021

If pregnant or breast-feeding,

ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 1/11/2021

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away 91-800-222-1222).

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/11/2021

Directions

  • take every 4 to 6 hours, or as directed by a doctor
  • do not take more than 6 times in 24 hours

adults and children 12 years and above

1-2 capsules

children 6 to under 12 years

1 capsule

children under 6 years

Ask a doctor

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 1/11/2021

Other information

*Tamper Evident: Do not use if safety seal under cap is broken or missing

  • store between 20°-25°C (68°-77°F)
  • protect from excessive moisture

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 1/11/2021

Inactive ingredients

black iron oxide, D&C red #28, D&C blue #1, FD&C red #40, gelatin, lactose monohydrate, magnesium stearate, silicon dioxide, sodium lauryl sulfate

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 1/11/2021

Questions?

Adverse drug event call (866)562-2756 Mon - Fri 8 AM to 4 PM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pharbedryl - FDA Drug Approval Details